Condition

Stage IIA Non-small Cell Lung Cancer

ClinicalTrials.gov condition label

Clinical trials16
Recruiting0
Common interventions25
Lead sponsors shown11

Clinical trials

16 shown
Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLCNCT05894889 · 2024-01-30
ACTIVE_NOT_RECRUITING
Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for SurgeryNCT02262325 · 2015-06-08
COMPLETED
Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family CaregiversNCT02243748 · 2015-02-05
COMPLETED
Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung CancerNCT02059889 · 2014-07-01
WITHDRAWN
Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLCNCT02059967 · 2014-03-01
WITHDRAWN
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer PatientsNCT01999881 · 2013-12-01
COMPLETED
Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor CareNCT01726296 · 2013-01-01
COMPLETED
Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung CancerNCT01741636 · 2013-01-01
COMPLETED
Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung CancerNCT01707823 · 2012-10-01
TERMINATED
An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)NCT01711697 · 2012-09-04
UNKNOWN
Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung CancerNCT01840150 · 2012-08-23
COMPLETED
Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant ChemotherapyNCT01595074 · 2012-05-01
NOT_YET_RECRUITING
Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryNCT01345851 · 2011-03-23
ACTIVE_NOT_RECRUITING
Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung CancerNCT01457469 · 2011-01-01
COMPLETED
Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical ResectionNCT00087269 · 2004-12-01
TERMINATED
Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by SurgeryNCT00049543 · 2002-09-01
COMPLETED

Common interventions

laboratory biomarker analysisOTHER8carboplatinDRUG3educational interventionOTHER3paclitaxelDRUG3quality-of-life assessmentPROCEDURE3questionnaire administrationOTHER3hypofractionated radiation therapyRADIATION2medical chart reviewOTHER2stereotactic body radiation therapyRADIATION23-dimensional conformal radiation therapyRADIATION14-dimensional computed tomographyDEVICE1acetylsalicylic acidDRUG1breath testPROCEDURE1cisplatinDRUG1counseling interventionOTHER1diffusion-weighted magnetic resonance imagingDEVICE1erlotinib hydrochlorideDRUG1etoposideDRUG1exercise interventionBEHAVIORAL1FDG-PETDEVICE1fludeoxyglucose F 18RADIATION1gefitinibDRUG1image-guided adaptive radiation therapyRADIATION1image-guided radiation therapyRADIATION1internet-based interventionOTHER1

Trial status mix

COMPLETED8
ACTIVE_NOT_RECRUITING2
TERMINATED2
WITHDRAWN2
NOT_YET_RECRUITING1
UNKNOWN1

Phase mix

NA7
PHASE13
PHASE23
EARLY_PHASE11
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.